374 related articles for article (PubMed ID: 33481009)
41. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome.
Richardson TG; Harrison S; Hemani G; Davey Smith G
Elife; 2019 Mar; 8():. PubMed ID: 30835202
[TBL] [Abstract][Full Text] [Related]
42. The Role of Genetic Variation of BMI, Body Composition, and Fat Distribution for Mental Traits and Disorders: A Look-Up and Mendelian Randomization Study.
Peters T; Nüllig L; Antel J; Naaresh R; Laabs BH; Tegeler L; Amhaouach C; Libuda L; Hinney A; Hebebrand J
Front Genet; 2020; 11():373. PubMed ID: 32373164
[TBL] [Abstract][Full Text] [Related]
43. An atlas of genetic correlations between gestational age and common psychiatric disorders.
Yao Y; Li C; Meng P; Cheng B; Cheng S; Liu L; Yang X; Jia Y; Wen Y; Zhang F
Autism Res; 2022 Jun; 15(6):1008-1017. PubMed ID: 35384380
[TBL] [Abstract][Full Text] [Related]
44. Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.
Jia X; Yang Y; Chen Y; Cheng Z; Du Y; Xia Z; Zhang W; Xu C; Zhang Q; Xia X; Deng H; Shi X
J Affect Disord; 2019 Jan; 242():234-243. PubMed ID: 30212762
[TBL] [Abstract][Full Text] [Related]
45. A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology.
Gupta P; Galimberti M; Liu Y; Beck S; Wingo A; Wingo T; Adhikari K; ; Stein MB; Gelernter J; Levey DF
medRxiv; 2024 Jan; ():. PubMed ID: 38293137
[TBL] [Abstract][Full Text] [Related]
46. Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study.
Hughes AM; Sanderson E; Morris T; Ayorech Z; Tesli M; Ask H; Reichborn-Kjennerud T; Andreassen OA; Magnus P; Helgeland Ø; Johansson S; Njølstad P; Davey Smith G; Havdahl A; Howe LD; Davies NM
Elife; 2022 Dec; 11():. PubMed ID: 36537070
[TBL] [Abstract][Full Text] [Related]
47. Causal effect of systemic lupus erythematosus on psychiatric disorders: A two-sample Mendelian randomization study.
Xue H; Liu S; Zeng L; Fan W
J Affect Disord; 2024 Feb; 347():422-428. PubMed ID: 38008292
[TBL] [Abstract][Full Text] [Related]
48. Systematic Mendelian randomization framework elucidates hundreds of CpG sites which may mediate the influence of genetic variants on disease.
Richardson TG; Haycock PC; Zheng J; Timpson NJ; Gaunt TR; Davey Smith G; Relton CL; Hemani G
Hum Mol Genet; 2018 Sep; 27(18):3293-3304. PubMed ID: 29893838
[TBL] [Abstract][Full Text] [Related]
49. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.
Liu J; Cheng Y; Li M; Zhang Z; Li T; Luo XJ
Neuropsychopharmacology; 2023 Jan; 48(2):270-280. PubMed ID: 36114287
[TBL] [Abstract][Full Text] [Related]
50. Attention-deficit/hyperactivity disorder and ischemic stroke: A Mendelian randomization study.
Du R; Zhou Y; You C; Liu K; King DA; Liang ZS; Ranson JM; Llewellyn DJ; Huang J; Zhang Z
Int J Stroke; 2023 Mar; 18(3):346-353. PubMed ID: 35670701
[TBL] [Abstract][Full Text] [Related]
51. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
[TBL] [Abstract][Full Text] [Related]
52. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease.
Chen J; Ruan X; Sun Y; Lu S; Hu S; Yuan S; Li X
EBioMedicine; 2024 Jan; 99():104934. PubMed ID: 38103512
[TBL] [Abstract][Full Text] [Related]
53. Genetic support of a causal relationship between cannabis use and educational attainment: a two-sample Mendelian randomization study of European ancestry.
Chen D; Wang X; Huang T; Jia J
Addiction; 2023 Apr; 118(4):698-710. PubMed ID: 36465060
[TBL] [Abstract][Full Text] [Related]
54. ADHD and its neurocognitive substrates: A two sample Mendelian randomization study.
Ahn K; Norman LJ; Justice CM; Shaw P
Transl Psychiatry; 2022 Sep; 12(1):378. PubMed ID: 36085199
[TBL] [Abstract][Full Text] [Related]
55. A transcriptome-wide Mendelian randomization study to uncover tissue-dependent regulatory mechanisms across the human phenome.
Richardson TG; Hemani G; Gaunt TR; Relton CL; Davey Smith G
Nat Commun; 2020 Jan; 11(1):185. PubMed ID: 31924771
[TBL] [Abstract][Full Text] [Related]
56. Shared genetic liability and causal effects between major depressive disorder and insomnia.
Baranova A; Cao H; Zhang F
Hum Mol Genet; 2022 Apr; 31(8):1336-1345. PubMed ID: 34761251
[TBL] [Abstract][Full Text] [Related]
57. Genetic susceptibility for schizophrenia after adjustment by genetic susceptibility for smoking: implications in identification of risk genes and genetic correlation with related traits.
Al-Soufi L; Costas J
Psychol Med; 2023 Mar; ():1-11. PubMed ID: 36876478
[TBL] [Abstract][Full Text] [Related]
58. Causal influences of neuroticism on mental health and cardiovascular disease.
Zhang F; Baranova A; Zhou C; Cao H; Chen J; Zhang X; Xu M
Hum Genet; 2021 Sep; 140(9):1267-1281. PubMed ID: 33973063
[TBL] [Abstract][Full Text] [Related]
59. Tissue specific regulation of transcription in endometrium and association with disease.
Mortlock S; Kendarsari RI; Fung JN; Gibson G; Yang F; Restuadi R; Girling JE; Holdsworth-Carson SJ; Teh WT; Lukowski SW; Healey M; Qi T; Rogers PAW; Yang J; McKinnon B; Montgomery GW
Hum Reprod; 2020 Feb; 35(2):377-393. PubMed ID: 32103259
[TBL] [Abstract][Full Text] [Related]
60. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.
Zhou H; Rentsch CT; Cheng Z; Kember RL; Nunez YZ; Sherva RM; Tate JP; Dao C; Xu K; Polimanti R; Farrer LA; Justice AC; Kranzler HR; Gelernter J;
JAMA Psychiatry; 2020 Oct; 77(10):1072-1080. PubMed ID: 32492095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
